Luiz Carlos Da Cunha

Dr. Luiz Carlos Da Cunha


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
DCDanilo Maciel Carneiro
Danilo Maciel Carneiro
RFRamias Calixto Freire
Ramias Calixto Freire
THTereza Cristina De Deus Honório
Tereza Cristina De Deus Honório
IZIury Zoghaib
Iury Zoghaib
FCFabiana Fernandes De S. E Silva Cardoso
Fabiana Fernandes De S. E Silva Cardoso
LCLuiz Carlos Da Cunha
Luiz Carlos Da Cunha
In this double‐blind, randomized clinical trial, 36 healthy male volunteers were randomly distributed into three groups (n = 12) that underwent a three‐step treatment. For four consecutive days, we alternately administered a standardized dried extract of Equisetum arvense (EADE, 900 mg/day), placebo (corn starch, 900 mg/day), or hydrochlorothiazide (25 mg/day), separated by a 10‐day washout period. Each volunteer served as his own control, and the groups’ results were compared. We repeated the same evaluation after each stage of treatment to evaluate the safety of the drug. The diuretic effect of EADE was assessed by monitoring the volunteers’ water balance over a 24 h period. The E. arvense extract produced a diuretic effect that was stronger than that of the negative control and was equivalent to that of hydrochlorothiazide without causing significant changes in the elimination of electrolytes. There was no significant increase in the urinary elimination of catabolites. Rare minor adverse events were reported. The clinical examinations and laboratory tests showed no changes before or after the experiment, suggesting that the drug is safe for acute use. Further research is needed to better clarify the mechanism of diuretic action and the other possible pharmacological actions of this phytomedicine.

1 June 2009 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
PDF file
LCLuiz Carlos Da Cunha
Luiz Carlos Da Cunha
FAFlaubertt S. Azeredo
Flaubertt S. Azeredo
AMAna C. V. Mendonça
Ana C. V. Mendonça
MVMarcelo S. Vieira
Marcelo S. Vieira
LPLiuba L. Pucci
Liuba L. Pucci
RJRuy de Souza Lino Junior
Ruy de Souza Lino Junior
O uso de plantas medicinais tem sido muito significativo nos últimos anos, sendo incentivado pela Organização Mundial de Saúde (OMS). Synadenium umbellatum Pax, Euphorbiacea (vulgo cola-nota, cancerola, milagrosa) tem o látex usado empiricamente como antitumoral e antiinflamatório. Por existir espécies tóxicas nesta família e visando à segurança no uso de extratos vegetais, tal estudo avaliou a toxicidade pré-clínica do látex e do extrato etanólico das folhas (EEF) de S. umbellatum, por via oral, em ratas Wistar. O estudo seguiu diretrizes do Guideline 423 (toxicidade aguda) e Guideline 407 (toxicidade subaguda) da OECD (Organisation for Economic Cooperation and Development). Na toxicidade aguda do látex e do EEF, não se observou letalidade nem alterações fisiológicas e comportamentais das ratas na dose de 2000 mg/kg, sendo praticamente atóxico. Porém, na análise histopatológica, o látex ocasionou congestão e infiltrado leucocitário nos rins, fígado e pulmões, efeitos não observados com o EEF. Na toxicidade subaguda, doses de 50, 100 e 200 mg/kg de EEF não produziram alterações dose-dependentes significativas nos parâmetros laboratoriais e fisiológicos, nem alterações macroscópicas e histopatológicas nos órgãos das ratas. Contudo, o uso crônico da planta S. umbellatum merece mais estudos. The use of medicinal plants has been being very significant in the last years, being the use encouraged by WHO. Synadenium umbellatum Pax, Euphorbiacea (popularly known as cola-note, cancerola, miraculous) has the latex used empirically as anti-cancerous and anti-inflammatory. For there being toxic species in this family and aiming at the safety in the use of vegetable extracts, such study evaluated the pre-clinical toxicity of the latex and of the ethanolic extract of the leaves (EEL) of S. umbellatum, administrated by oral route, in Wistar female rats. The study followed OECD's Guidelines for test of acute toxicity (Guideline 423) and for subacute toxicity (Guideline 407). In the acute toxicity of latex and EEL, behavioral and physiological alterations were not observed neither animal's death in the dose level of 2,000 mg/kg. However, the latex caused congestion and leukocytes infiltration of the kidneys, liver and lungs, effects not observed with EEL. In the subacute toxicity, dose levels of 50, 100 and 200 mg/kg of EEL did not produced significant dose-dependent alterations in the lab results and no physiologic, macroscopic and hystopathological alterations. EEL of S. umbellatum is practically poisonless in acute exposure; already the latex can cause hystological damages. The chronic use of S. umbellatum needs more specific studies

30 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
RSRávila Graziany Machado de Souza
Rávila Graziany Machado de Souza
AGAline Corado Gomes
Aline Corado Gomes
PNPaula Andrea Navarro
Paula Andrea Navarro
LCLuiz Carlos Da Cunha
Luiz Carlos Da Cunha
MSMarina Silva
Marina Silva
JMJoão Mota
João Mota
Background: Obesity-induced inflammation is frequently associated with higher oxidative stress. In vitro and experimental studies have considered baru almonds (Dipteryx alata Vog) as a legume seed with high antioxidant capacity. The aim of this study was to evaluate whether baru almonds are capable of improving the inflammatory and antioxidant status in overweight and obese women. Methods: In a parallel-arm, randomized placebo-controlled trial, 46 overweight and obese women (age: 40 ± 11 years; body mass index: 33.3 ± 4.3) were randomly assigned to receive advice to follow a normocaloric and isoenergetic diet with placebo (PLA, n = 22) or similar advice plus 20 g baru almonds (BARU, n = 24) for 8 wk. Malondialdehyde (MDA), adiponectin, tumor necrosis factor-α, interleukin-6, interleukin-10, antioxidant enzymes activities (catalase—CAT; glutathione peroxidase—GPx; superoxide dismutase—SOD), and minerals were analyzed in plasma samples. Results: At baseline, groups were similar regarding the body composition, oxidative, and inflammatory parameters. The BARU group increased the activity of GPx (+0.08 U/mg, 95%CI + 0.05 to +0.12 vs. −0.07, 95%CI −0.12 to −0.03, p < 0.01) and plasma copper concentration (p = 0.037) when compared to the PLA group. No differences were observed between groups in CAT and SOD activity or MDA and cytokines concentrations. Conclusions: Baru almond supplementation increased the GPx activity in overweight and obese women.

9 November 2022 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
NSNayara Cristina Freitas e Silva-Santana
Nayara Cristina Freitas e Silva-Santana
HRHellen Christina Neves Rodrigues
Hellen Christina Neves Rodrigues
TMTatiane Fagundes Pereira Martins
Tatiane Fagundes Pereira Martins
CBClarice Carneiro Braga
Clarice Carneiro Braga
MSMarina Silva
Marina Silva
MPMaria do Rosário Peixoto
Maria do Rosário Peixoto

1 January 2013 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
RBRodrigo Borges
Rodrigo Borges
MNMarcus Vinícius Mariano Nascimento
Marcus Vinícius Mariano Nascimento
ACAdryano Augustto Valladão de Carvalho
Adryano Augustto Valladão de Carvalho
MVMarize Valadares
Marize Valadares
JPJosé Realino de Paula
José Realino de Paula
LCLuiz Carlos Da Cunha
Luiz Carlos Da Cunha
Synadenium umbellatumPax., popularly known in Brazil as “cola-nota,” “avelós,” “cancerola,” and “milagrosa”, is a plant species used in folk medicine for the treatment of inflammation, pain, and several diseases. This study aimed to investigate the antinociceptive and anti-inflammatory activities of the ethanolic extract fromSynadenium umbellatumPax. leaves (EES) and its hexane (HF), chloroform (CF), and methanol/water (MF) fractions using the acetic acid-induced abdominal writhing test, formalin-induced paw licking test, tail flick test, croton oil-induced ear edema test, and carrageenan-induced peritonitis test. EES and MF reduced the number of acetic acid-induced abdominal writhes, while CF and HF did not. EES effect on acetic acid-induced abdominal writhing was reversed with a pretreatment with naloxone. EES reduced licking time in both phases of the formalin-induced paw licking test, but did not prolong the latency in the tail flick test. These results show that EES presented antinociceptive activity, probably involving the opioid system, anti-inflammatory activity in the croton oil-induced ear edema test, and leukocyte migration into the intraperitoneal cavity. MF also presented anti-inflammatory activity in the croton oil-induced ear edema test. In conclusion, EES and MF have antinociceptive activity involving the opioid system and anti-inflammatory activity.

1 December 2008 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Open access
PDF file
LCLuiz Carlos Da Cunha
Luiz Carlos Da Cunha
FUFaculdade de Farmácia / UFG
Faculdade de Farmácia / UFG
VSVinícius Augusto de Sá
Vinícius Augusto de Sá
MAMarcos Evaristo da Paixão e Amorim
Marcos Evaristo da Paixão e Amorim
IBIsabel Cristina Medeiros Barros
Isabel Cristina Medeiros Barros
NSNusa da Silveira
Nusa da Silveira
The Brosimum gaudichaudii Trécul. (BG) Moraceae, with a high frequency in regions of the Brazilian cerrado (shrubland) and popularly known as "mamacadela", holds photosensitizing furocoumarins. The BG's main therapeutic use is the treatment of vitiligo, a skin depigmentation disease that takes hold of approximately 1-2 % of the world population. There is one product on the marketplace (Viticromin®), for which there is no scientific research available about its experimental toxicity, in spite of its proven clinical efficacy. Therefore, the development of acute pre-clinical toxicity trials has been proposed (approximate lethal dose, ALD, and median lethal dose, LD50) of the BG root exsudate in laboratory animals. Male, albino mice weighing between 25 and 30 g, in good sanitation conditions have been used. The mice received water and food ad libitum. The BG powder was mixed in 0.9% saline solution and 0.5% cremophor and was administered po and ip. The LD50 was obtained through the Lichtfield and Wilcoxon (1949) method. A public domain software was used for the calculations. Ten mice/dose were used - 6 groups for each administration via, including the control group - and the number of deaths within up to 14 days was considered; the control group received an emulsion made up by 0.9 saline solution and 0.5% cremophor. Before establishing the LD50 and aiming at reducing the number of animals used, the DLA was determined when 1 animal per dose was used (the next dose always 50% higher than the previous dose), until identifying the dose that led to the death of 1 animal. Thus, the DLA po was 3750 mg/kg and the DLA ip, 2920 mg/kg. The LD50 po was 3517.54 mg/kg and the LD50 ip was 2871.76 mg/kg. The product was considered as of being of low toxicity, taking into account only the single dose acute toxicity. O Brosimum gaudichaudii Trécul. (BG) família Moraceae, é largamente distribuído nas regiões de cerrado do Brasil e é popularmente conhecido como "mamacadela" e possui, na sua composição química, furocumarinas fotossensibilizantes. O principal uso terapêutico do BG é no tratamento do vitiligo, uma doença despigmentante da pele com prevalência de aproximadamente 1-2% da população mundial. Há um produto no mercado (Viticromin®), que é comercializado com tal finalidade, havendo poucos dados disponíveis acerca da toxicidade experimental, ao lado de eficácia clínica comprovada. Portanto, o desenvolvimento de estudos de toxicidade pré-clínica foi proposto (dose letal aproximada, DLA e dose letal mediana, DL50) para o exsudato da raiz de BG em animais de laboratório. Foram utilizados camundongos machos, albinos, pesando entre 25 e 30 g, em boas condições sanitárias, recebendo água e ração ad libitum. O pó de BG foi suspenso em solução salina 0,9% com 0,5% de cremofor e administrado p.o. (gavage) e intraperitonealmente. A DL50 foi obtida através do método de regressão linear de Lichtfield & Wilcoxon (1949), utilizando um software de domínio público. Foram formados 6 grupos de 10 animais para cada via de administração, incluindo grupo controle, e o número de mortes foi observado durante 14 dias; o grupo controle recebeu uma emulsão de solução salina 0,9% com 0,5% de cremofor. Antes de estabelecer a DL50 e visando reduzir o número de animais utilizados, determinou-se a DLA, utilizando 1 animal por dose (a próxima dose 50% maior do que a dose anterior), até identificar a dose letal para 1 animal. Assim, a DLA p.o. foi de 3750 mg/kg e a DLA i.p., 2920 mg/kg. A DL50 p.o. foi de 3517,54 mg/kg e a DL50 i.p. foi 2871,76 mg/kg. O produto foi considerado possuir baixa toxicidade, considerando apenas uma dose neste ensaio de toxicidade aguda